Presentation TCT 2021 Oral Anticoagulation Should Be the Default Strategy After LAAC Presenter: Matthew J. Price November 06, 2021
Presentation TCT 2021 Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC Presenter: Jacqueline Saw November 06, 2021
Presentation TCT 2021 Captis: Full-Body Embolic Protection Device Presenter: Haim Danenberg November 04, 2021
Presentation TCT 2019 Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices Presenter: Horst Sievert September 27, 2019
Presentation TCT 2019 TCT 120: Utilization of Percutaneous Thrombectomy in Patients with Massive and Very High-risk Submassive Acute Pulmonary Embolism Presenter: Catalin Toma September 25, 2019
Presentation TCT 2019 TCT 119: Reduced Mortality in Severe PE with Ultrasound-Assisted Catheter-Directed Thrombolysis: A Single Center Experience. Presenter: Shayan Nabavi Nouri September 25, 2019
Presentation TCT 2019 TCT 118: Balloon pulmonary angioplasty for segmental and sub segmental thromboembolic lesions in patients with chronic thromboembolic pulmonary hypertension Presenter: Vladimir Losev September 25, 2019
Presentation TCT 2019 TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty. Presenter: Stanislaw Jankiewicz September 25, 2019
Presentation TVT 2019 Endovascular Repair of Left Ventricular Assist Device Outflow Tract Kink Presenter: Rohit Vyas June 13, 2019
Presentation JIM 2019 LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing? Presenter: Maurice Buchbinder February 14, 2019
Presentation The Structural Heart Disease Summit 2018 How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making Presenter: James B. Hermiller Jr, Saibal Kar, Megan Coylewright June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines Presenter: John D. Carroll, Brij Maini, Lars Sondergaard June 23, 2018
Presentation The Structural Heart Disease Summit 2018 An Integrated Strategy to Prevent Both Ischemic and Hemorrhagic Strokes Presenter: Robert J. Sommer, Brian K. Whisenant, Rajan Gadhia June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia June 22, 2018
Presentation TCT 2017 High-Risk AF Patients: Changing the Emphasis From Stroke Prevention to Stroke and Hemorrhagic Complication Avoidance Presenter: Christopher B. Granger, Horst Sievert, Michael D. Ezekowitz October 30, 2017
Presentation TCT 2017 How to Calculate Stroke and Bleeding Risk in Clinical Practice Presenter: Christopher B. Granger, Horst Sievert, Ted Feldman October 30, 2017
Presentation TCT 2017 LAA Closure: Underused Therapy in Patients With High Bleeding Risk Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne October 29, 2017
Presentation LAA 2017 PFO Case Reviews: To Close or Not to Close Presenter: David E. Thaler July 22, 2017
Presentation LAA 2017 Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries Presenter: David E. Thaler July 22, 2017